menu
    • menu
    [{"orgOrder":0,"company":"Jiangsu Aidea Pharmaceutical","sponsor":"Chengdu Aidea Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CHINA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"ACC017","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Jiangsu Aidea Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Jiangsu Aidea Pharmaceutical \/ Chengdu Aidea Pharmaceutical","highestDevelopmentStatusID":"6","companyTruncated":"Jiangsu Aidea Pharmaceutical \/ Chengdu Aidea Pharmaceutical"},{"orgOrder":0,"company":"Jiangsu Aidea Pharmaceutical","sponsor":"Chengdu Aidea Pharmaceutical","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"ACC017","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I\/ Phase II","graph3":"Jiangsu Aidea Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Jiangsu Aidea Pharmaceutical \/ Chengdu Aidea Pharmaceutical","highestDevelopmentStatusID":"7","companyTruncated":"Jiangsu Aidea Pharmaceutical \/ Chengdu Aidea Pharmaceutical"}]

    Find Clinical Drug Pipeline Developments & Deals by Jiangsu Aidea Pharmaceutical

    Menu

    Jiangsu Aidea Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Jiangsu Aidea Pharmaceutical

                            China arrow
                            CTAD25
                            Not Confirmed

                            Jiangsu Aidea Pharmaceutical

                            China arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ACC017

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase I/ Phase II

                            Sponsor : Chengdu Aidea Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase Ib/IIa Clinical Study of ACC017 Tablets

                            Details : ACC017 is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of HIV Infections.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            December 05, 2024

                            Lead Product(s) : ACC017

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : Chengdu Aidea Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Jiangsu Aidea Pharmaceutical

                            China arrow
                            CTAD25
                            Not Confirmed

                            Jiangsu Aidea Pharmaceutical

                            China arrow
                            CTAD25
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : ACC017

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Chengdu Aidea Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants

                            Details : ACC017 is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            February 26, 2024

                            Lead Product(s) : ACC017

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Chengdu Aidea Pharmaceutical

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth